These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 18458033)

  • 1. Parietal epithelia cells in the urine as a marker of disease activity in glomerular diseases.
    Achenbach J; Mengel M; Tossidou I; Peters I; Park JK; Haubitz M; Ehrich JH; Haller H; Schiffer M
    Nephrol Dial Transplant; 2008 Oct; 23(10):3138-45. PubMed ID: 18458033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Podocalyxin-positive glomerular epithelial cells in urine correlate with a positive outcome in FSGS.
    Mueller-Deile J; Kümpers P; Achenbach J; Park JK; Mengel M; Haller H; Schiffer M
    J Nephrol; 2012; 25(5):802-9. PubMed ID: 22241637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical evaluation of podocalyxin expression in glomerulopathies associated with nephrotic syndrome.
    Kavoura E; Gakiopoulou H; Paraskevakou H; Marinaki S; Agrogiannis G; Stofas A; Boletis I; Patsouris E; Lazaris AC
    Hum Pathol; 2011 Feb; 42(2):227-35. PubMed ID: 21106221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoexpression of podocyte-associated proteins in acquired human glomerulopathies with nephrotic syndrome.
    Wagrowska-Danilewicz M; Stasikowska O; Danilewicz M
    Pol J Pathol; 2006; 57(1):17-21. PubMed ID: 16739878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats.
    Chen CA; Hwang JC; Guh JY; Chang JM; Lai YH; Chen HC
    J Lab Clin Med; 2006 Feb; 147(2):74-82. PubMed ID: 16459165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apical cell membranes are shed into urine from injured podocytes: a novel phenomenon of podocyte injury.
    Hara M; Yanagihara T; Kihara I; Higashi K; Fujimoto K; Kajita T
    J Am Soc Nephrol; 2005 Feb; 16(2):408-16. PubMed ID: 15625073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical detection of galectin-1 in renal biopsy specimens of children and its possible role in proteinuric glomerulopathies.
    Ostalska-Nowicka D; Zachwieja J; Nowicki M; Kaczmarek E; Siwińska A; Witt M
    Histopathology; 2007 Oct; 51(4):468-76. PubMed ID: 17880528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Podocyte membrane vesicles in urine originate from tip vesiculation of podocyte microvilli.
    Hara M; Yanagihara T; Hirayama Y; Ogasawara S; Kurosawa H; Sekine S; Kihara I
    Hum Pathol; 2010 Sep; 41(9):1265-75. PubMed ID: 20447677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary excretion of IGFBP-1 and -3 correlates with disease activity and differentiates focal segmental glomerulosclerosis and minimal change disease.
    Worthmann K; Peters I; Kümpers P; Saleem M; Becker JU; Agustian PA; Achenbach J; Haller H; Schiffer M
    Growth Factors; 2010 Apr; 28(2):129-38. PubMed ID: 20102313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary glycosaminoglycan composition in chronic glomerulonephritis.
    De Muro P; Faedda R; Satta A; Finetti D; Masala A; Cigni A; Sanna GM; Cherchi GM
    J Nephrol; 2005; 18(2):154-60. PubMed ID: 15931643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary sediment features in proliferative and non-proliferative glomerular diseases.
    Fogazzi GB; Saglimbeni L; Banfi G; Cantú M; Moroni G; Garigali G; Cesana BM
    J Nephrol; 2005; 18(6):703-10. PubMed ID: 16358228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between urinary podocytes and kidney diseases.
    Sun D; Zhao X; Meng L
    Ren Fail; 2012; 34(3):403-7. PubMed ID: 22250862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Cell Membrane Antigens in Cells Excreted in the Urinary Sediment Predicts Progression of Renal Disease in Patients with Focal Segmental Glomerulosclerosis.
    Konieczny A; Czyżewska-Buczyńska A; Ryba M; Rukasz D; Krajewska M; Witkiewicz W; Hruby Z
    Am J Nephrol; 2015; 42(1):35-41. PubMed ID: 26337565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathology of nondiabetic glomerular disease among adult Iraqi patients from a single center.
    Hashim Al-Saedi AJ
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):858-61. PubMed ID: 19736492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of early phenotypic change of glomerular podocytes detected by Pax2 in primary focal segmental glomerulosclerosis.
    Ohtaka A; Ootaka T; Sato H; Soma J; Sato T; Saito T; Ito S
    Am J Kidney Dis; 2002 Mar; 39(3):475-85. PubMed ID: 11877566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of proteinuria in primary glomerulonephritides: urinary polymers of albumin.
    Bazzi C; Petrini C; Rizza V; Arrigo G; Beltrame A; D'Amico G
    Am J Kidney Dis; 1997 Sep; 30(3):404-12. PubMed ID: 9292570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary podocytes in primary focal segmental glomerulosclerosis.
    Hara M; Yanagihara T; Kihara I
    Nephron; 2001 Nov; 89(3):342-7. PubMed ID: 11598401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulation of podocyte phenotype in idiopathic collapsing glomerulopathy and HIV-associated nephropathy.
    Yang Y; Gubler MC; Beaufils H
    Nephron; 2002 Jul; 91(3):416-23. PubMed ID: 12119471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrastructural features and expression of cytoskeleton proteins of podocyte from patients with minimal change disease and focal segmental glomerulosclerosis.
    Shi SF; Wang SX; Zhang YK; Zhao MH; Zou WZ
    Ren Fail; 2008; 30(5):477-83. PubMed ID: 18569926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of podocyte phenotype in collapsing glomerulopathies.
    Barisoni L; Kopp JB
    Microsc Res Tech; 2002 May; 57(4):254-62. PubMed ID: 12012394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.